Clinical Trials
4 trialsNCT06190899 2026-04-13
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Celcuity Inc
Phase 1/2 Recruiting
NCT05367440 2025-12-08
PETRANHA
AstraZeneca
Phase 1/2 Active not recruiting
NCT04737109 2023-11-13
ADDItion
Big Ten Cancer Research Consortium
Phase 1/2 Terminated
NCT01317641 2017-03-29
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
Orion Corporation, Orion Pharma
Phase 1/2 Completed